Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?
Anastasios Kyriazoglou, 1 Konstantinos Koutsoukos, 1 Flora Zagouri, 1 Michalis Liontos, 1 Efthimios Dimitriadis, 2 Dina Tiniakos, 3, 4 Meletios Athanasios Dimopoulos 1 1Department of Clinical Therapeutics, General Hospital Alexandra, Athens, Greece; 2Department of Genetics, Agios Savvas Hospital,...
Guardado en:
Autores principales: | Kyriazoglou A, Koutsoukos K, Zagouri F, Liontos M, Dimitriadis E, Tiniakos D, Dimopoulos MA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b68771081f1d4a1aa43e7c3169c4d690 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multifocal Epithelioid Hemangioendothelioma Complicated with Disseminated Intravascular Coagulation
por: Hiroaki Kimura, et al.
Publicado: (2021) -
Clinical, dermoscopic and histopathologic findings of retiform hemangioendothelioma
por: Amanda Mota, et al.
Publicado: (2013) -
Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma
por: Pender A, et al.
Publicado: (2017) -
Thoracic composite hemangioendothelioma with neuroendocrine marker expression
por: Ei Miyamoto, et al.
Publicado: (2021) -
Rosette-forming epithelioid osteosarcoma in the rib: a rare case of location and morphology
por: Sun-Ju Oh
Publicado: (2021)